home / stock / mxct / mxct articles

MXCT Articles, MaxCyte Inc. - From 10/05/23

Stock Information
Company Name: MaxCyte Inc.
Stock Symbol: MXCT
Market: NASDAQ
Website: maxcyte.com
Menu
MXCT MXCT Quote MXCT Short MXCT News MXCT Articles MXCT Message Board
Get MXCT Alerts

News, Short Squeeze, Breakout and More Instantly...
Cell Engineering MaxCyte Faces Challenge, Analysts Express Concerns Over Near-Term Prospects Amid Revenue Decline | Benzinga

MaxCyte Inc (NASDAQ: MXCT) shares plummeted after the company released preliminary Q3 revenue of $7.8 million – 8.0 million, a Y/Y decre...
Crude Oil Down 2%; ConAgra Brands Earnings Top Views | Benzinga

U.S. stocks traded slightly lower toward the end of trading, with the Dow Jones index falling around 40 points on Thursday. The Dow traded down 0.1...

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin...

Dow Tumbles Over 100 Points; Constellation Brands Raises Profit Forecast | Benzinga

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.45% to 32...
Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket | Benzinga

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares rose 95.5% to $15.80 in pre-market trading after the company inked a deal with Kyowa Kirin...

MaxCyte, Rivian Automotive And Other Big Stocks Moving Lower In Thursday's Pre-Market Session | Benzinga

U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session. C...

Conagra Brands, Constellation Brands And 3 Stocks To Watch Heading Into Thursday | Benzinga

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows: Wall Street ...
MaxCyte to Participate in Baird Global Healthcare Conference | Benzinga

ROCKVILLE, Md., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT)), a leading commercial cell-engineering company focus...

MAXCYTE: A PIONEER IN THE CELL THERAPY MARKET

The Company has developed an innovative platform with a highly effective revenue model in place, which should help it rise to new heights.

Previous 10 Next 10